Clinical Trials in Reggio Emilia, Reggio Emilia
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Neuroendocrine TumorsLung Neuroendocrine NeoplasmThymus Neoplasms
Grupo Espanol de Tumores Neuroendocrinos120 enrolled27 locationsNCT05918302
Recruiting
Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma ( FL)
Genmab1,095 enrolled265 locationsNCT06191744
Recruiting
Phase 1
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Philogen S.p.A.42 enrolled2 locationsNCT07245992
Recruiting
Phase 3
Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB
Colorectal, CancerMetastatic Colorectal CancerRAS Mutation
Azienda USL Reggio Emilia - IRCCS280 enrolled4 locationsNCT04776655
Recruiting
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Breast CancerColorectal, CancerProstate Cancer+5 more
University of Modena and Reggio Emilia45 enrolled1 locationNCT06236373